Homomultivalent Polymeric Nanotraps Disturb Lipid Metabolism Homeostasis and Tune Pyroptosis in Cancer

Abstract

Genetic manipulations and pharmaceutical interventions to disturb lipid metabolism homeostasis have emerged as an attractive approach for the management of cancer. However, the research on the utilization of bioactive materials to modulate lipid metabolism homeostasis remains constrained. In this study, we have utilized heptakis (2,3,6‐tri‐O‐methyl)‐β‐cyclodextrin (TMCD) to fabricate homomultivalent polymeric nanotraps, and surprisingly find it has an unprecedented ability to perturb lipid metabolism homeostasis and induce pyroptosis in tumor cells. Through modulation of the density of TMCD arrayed on the polymers, one top‐performing nanotrap, PTMCD4, exhibits the most powerful cholesterol‐trapping and depletion capacity, thus achieving prominent cytotoxicity toward different types of tumor cells and encouraging antitumor effects in vivo. The interactions between PTMCD4 and biomembranes of tumor cells effectively enable the reduction of cellular phosphatidylcholine and cholesterol levels, thus provoking damage to the biomembrane integrity and perturbation of lipid metabolism homeostasis. Additionally, the interplays between PTMCD4 and lysosomes also induce lysosomal stress, activate the nucleotide‐binding oligomerization domain (NOD)‐like receptor protein 3 (NLRP3) inflammasomes, and subsequently trigger tumor cell pyroptosis. To sum up, this study first introduces dendronized bioactive polymers to manipulate lipid metabolism and has shed light on another innovative insight for cancer therapy.This article is protected by copyright. All rights reserved